Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders??? Equity (Deficit)

v3.22.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Series C
Series D
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Series D
Accumulated Other Comprehensive (Loss)
Accumulated Deficit
Balance as of beginning of period (in shares) at Dec. 31, 2019 27,967,896              
Balance as of beginning of period at Dec. 31, 2019 $ 101,858              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Issuance of redeemable convertible preferred stock, net of issuance costs (in shares) 75,660,962              
Issuance of redeemable convertible preferred stock and common stock, net of issuance costs $ 28,153              
Exchange of convertible notes and accrued interest for Series D redeemable convertible preferred stock (in shares) 18,561,773              
Exchange of convertible notes and accrued interest for Series D redeemable convertible preferred stock $ 6,967              
Extinguishment of redeemable convertible preferred stock (in shares) (4,456,248)              
Extinguishment of redeemable convertible preferred stock $ (13,274)              
Balance as of end of period (in shares) at Dec. 31, 2020 117,734,383 8,399,058 94,222,735          
Balance as of end of period at Dec. 31, 2020 $ 123,704 $ 39,378 $ 35,120          
Balance as of beginning of period (in shares) at Dec. 31, 2019       14,721,523        
Balance as of beginning of period at Dec. 31, 2019 $ (100,823)     $ 1 $ 13,196     $ (114,020)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares) 55,000     71,522        
Issuance of common stock upon exercise of stock options $ 53       53      
Issuance of common stock warrants     $ 27     $ 27    
Extinguishment of redeemable convertible preferred stock (in shares)       1,210,513        
Extinguishment of redeemable convertible preferred stock 13,274       223     13,051
Stock-based compensation 1,455       1,455      
Net loss (21,807)             (21,807)
Balance as of end of period (in shares) at Dec. 31, 2020       16,003,558        
Balance as of end of period at Dec. 31, 2020 $ (107,821)     $ 1 14,954     (122,776)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Conversion of preferred stock into common stock (in shares) (124,681,207)              
Conversion of preferred stock into common stock $ (180,180)              
Conversion of warrants into preferred stock, net settlement (in shares) 126,802              
Conversion of warrants into preferred stock, net settlement $ 899              
Conversion of convertible notes into preferred stock (in shares) 6,820,022              
Conversion of convertible notes into preferred stock $ 55,577              
Balance as of end of period (in shares) at Dec. 31, 2021 0              
Balance as of end of period at Dec. 31, 2021 $ 0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of preferred stock into common stock (in shares)       126,310,700        
Conversion of preferred stock into common stock $ 180,180       180,180      
Issuance of common stock upon exercise of stock options (in shares) 269,000     269,112        
Issuance of common stock upon exercise of stock options $ 385       385      
Issuance of common stock warrants 316       316      
Conversion of warrants into common stock, net settlement (in shares)       239,992        
Conversion of warrants into common stock, net settlement 3,635       3,635      
Issuance of contingent earnout liability upon the reverse recapitalization (120,763)       (120,763)      
Issuance of warrants upon the reverse recapitalization (21,051)       (21,051)      
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)       40,409,132        
Issuance of common stock upon the reverse recapitalization, net of issuance costs 278,271     $ 1 278,270      
Stock-based compensation 4,368       4,368      
Net loss (107,091)             (107,091)
Other comprehensive loss (14)           $ (14)  
Balance as of end of period (in shares) at Dec. 31, 2021       183,232,494        
Balance as of end of period at Dec. 31, 2021 $ 110,415     $ 2 $ 340,294   $ (14) $ (229,867)